期刊文献+

抗人DR5单克隆抗体的制备、鉴定及活性分析 被引量:4

Preparation,characterization,and activity analysis of monoclonal antibodies against human death receptor 5
下载PDF
导出
摘要 目的制备抗人DR5单克隆抗体(mAb),鉴定其特性,并进行生物学活性分析。方法以纯化的可溶性DR5(sDR5)免疫Balb/c小鼠,杂交瘤技术制备抗人DR5mAb;运用ELISA、SDS-PAGE电泳方法测定抗DR5mAb与sDR5结合的特性;Ig亚类ELISA试剂盒鉴定抗DR5mAb亚类;间接ELISA法检测腹水mAb效价;流式细胞仪检测肿瘤细胞表面DR5的表达水平;流式细胞仪检测抗DR5单克隆抗体(mAb)诱导肿瘤细胞凋亡的功能。结果获得1株可分泌抗DR5mAb的杂交瘤细胞系R150。SDS-PAGE电泳检测证实,获得的R150可特异性地识别DR5;R150的Ig亚类为IgGI(λ型);腹水效价为1×106;通过流式细胞仪可敏感地检测到肿瘤细胞表面DR5的表达水平及R150诱导肿瘤细胞凋亡情况。结论获得1株可分泌抗DR5mAb的细胞系R150,抗体具有效价高、特异性强等特点并能有效诱导肿瘤细胞凋亡,具有较好的应用价值。 Objective To prepare monoclonal antibodies (mAbs) against DR5,and characterize their biological properties by using ELISA,flow cytometry,and SDS-PAGE. Methods Balb/c mice were immunized with soluble DR5 (sDR5),and then mAbs was prepared by hybridoma technique. Ig subclass and specificity of mAbs were analyzed by ELISA and SDS-PAGE,respectively. The titres of mAbs in ascitic fluid were determined by indirect ELISA. Flow cytometry was utilized to detect the tumor cell apoptosis-inducing activity of the mAbs a...
出处 《免疫学杂志》 CAS CSCD 北大核心 2009年第6期671-675,共5页 Immunological Journal
基金 福建省自然科学基金(C0710046)资助
关键词 死亡受体5 TRAIL 单克隆抗体 细胞凋亡 death receptor 5 TRAIL monoclonal antibody apoptosis
  • 相关文献

参考文献5

二级参考文献18

共引文献26

同被引文献30

  • 1赵泽文,梁志清,史常旭,常青,陈勇.抗rhEndoglin单链抗体的可溶性表达、纯化及活性鉴定[J].免疫学杂志,2009,25(1):56-60. 被引量:2
  • 2RaymondADANIELS,HelenTURLEY,FionaCKIMBERLEY,XueSongLIU,JuthathipMONGKOLSAPAYA3,PaulCH'EN,XiaoNingXU,BoquanJIN,FrancescoPEZZELLA,GavinRSCREATON.Expression of TRAIL and TRAIL receptors in normal and malignant tissues[J].Cell Research,2005,15(6):430-438. 被引量:22
  • 3宋玉国,李文珠,李迎,陈彩霞,庄国洪.FasL、抗人DR5单克隆抗体诱导肿瘤细胞凋亡的研究[J].中国免疫学杂志,2007,23(1):38-41. 被引量:4
  • 4李淑莲,马远方,刘广超,张军,白慧玲,刘英杰,卢峰.抗人DR5单克隆抗体mDRA-6对HL-60细胞的诱导凋亡作用[J].免疫学杂志,2007,23(3):295-297. 被引量:5
  • 5Pan G, Ni J, Wei YF, et al. An antagonist decoy receptor and a death domain-containing receptor for TRAIL [J]. Science, 1997, 277 (5237): 815-818.
  • 6Ichikawa K, Liu W, Zhao L, et al. Tumoricidal activity of a novel anti human DR5 monoclonal antibody without hepat~yte cytotoxicity [J]. Nat Med, 2001, 7 (8):954-960.
  • 7Frederick PJ,Kendrick JE,Straughn JM Jr, et al. Effect of TRA- 8 anti-death receptor 5 antibody in combination with chemotherapy in an ex vivo human ovarian cancer mode[J]. Int J Gynecol Cancer, 2009, 19(5):814-819.
  • 8Yada A, Yazawa M, Ishida S, et al. A novel humanized anti-human death receptor 5 antibody CS-1008 induces apoptosis in tumor cells without toxicity in hepatoeytes [J]. Ann Oncol, 2008, 19(6):1060- 1067.
  • 9Lv F, Qiu Y, Zhang Y, et al. Adeno-associated virus-mediated anti-DR5 chimeric antibody expression suppresses human tumor growth in nude mice[J]. Cancer Lett, 2011.302(2): 119- 127.
  • 10Lee SH, Park DW, Sung ES, et ai. Humanization of an agonistic anti-death receptor 4 single chain variable fragment antibody and avidity-mediated enhancement of its cell death-inducing activity[J]. Mol Immunol, 2010, 47(4): 816-824.

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部